Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma (Q80389439)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 August 2004
edit
Language Label Description Also known as
English
Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma
scientific article published on 01 August 2004

    Statements

    title
    Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15280789
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15280789%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    31 December 2019
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q80389439&oldid=1786016873"